A new study suggests that more women are being prescribed beta-3 agonists over anticholinergics for the treatment of overactive bladder (OAB), suggesting that more clinicians may be choosing this ...

Bladder leaks can be disruptive—and they’re very common. Up to 30 percent of older adults experience incontinence. The problem is more prevalent in women, but the percentage of men with an overactive ...

After successful Phase 3 trials, Indevus Pharmaceuticals Inc. has received a $10 million milestone payment from its partner in the development of overactive-bladder drugs Sanctura and Sactura XR, ...

New Managed Care Findings from Kaiser Permanente Described (Primary Nonadherence to Overactive Bladder Medications in an Integrated Managed Care Health Care System) By a News Reporter-Staff News ...

TOKYO, June 18 (Reuters) - Japan's Astellas Pharma <4503.T> said on Friday it was seeking approval from Japanese health authorities for a bladder control drug. Sign up here. The company said it was ...

July 28 (Reuters) - Targacept Inc said it was stopping development of a drug to treat overactive bladder after it failed to show significant reduction in incontinence in a mid-stage study. The company ...